Pharmacogenomic samples, testing and data handling

Current version

PDF iconReflection paper

Reference numberEMEA/CHMP/PGxWP/201914/06
Published15/11/2007
KeywordsPharmacogenomics (PG), pharmacogenomic evaluation
DescriptionThis document highlights some key principles to be considered by both the pharmaceutical industry and the assessors for pharmacogenomics sampling in clinical trials intended for regulatory submission.


Document history

First version

Current version

PDF iconReflection paper


PDF iconOverview of comments

Published: 15/11/2007


Published: 02/04/2007


Related content


How useful was this page?

Add your rating